Organization
University of Genoa
4 abstracts
Abstract
Impact of hormone receptor status and tumor subtypes on clinical behavior and outcomes of breast cancer in young BRCA carriers.Org: Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy, Academic Trials Promoting Team, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium, U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France, Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea,
Abstract
Dose-dense adjuvant chemotherapy in patients with HER2-low early breast cancer: An exploratory analysis of the GIM2 trial.Org: Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Clinical Oncology Department, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Department of Clinical Medicine and Surgery, Università Federico II, Napoli, Italy, Medical Oncology Department, ASL FR, Frosinone, Italy, Precision Medicine Unit in Senology Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy,
Abstract
Immune checkpoint inhibitor in high-risk oral potentially malignant disorders (IMPEDE study): An interim analysis on safety.Org: University of Brescia, ASST Spedali Civili - Brescia, Angelo Nocivelli Institute of Molecular Medicine, University of Brescia and ASST-Spedali Civili, ASST-Spedali Civili of Brescia,
Abstract
AUTOANTIBODY STATUS IN DERMATOMYOSITIS AND POLYMYOSITIS PATIENTS DEFINES BOTH CANCER RISK AND SURVIVAL WITH ANA NEGATIVITY IN CASES WITH CONCOMITANT CANCER HAVING A WORSE SURVIVALOrg: Sheba Medical Center, Or-Yeuda, Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Musculoskeletal Medicine, Leeds, United Kingdom, University of Genoa, Clalit Health Services,